A mixed performance in the stock price over the year has left investors unsure of what to expect, resulting in a range of outlooks from optimistic to pessimistic. The index has shown a price loss of -6.00% this year. Over the last six months, there has been a weaker performance of 5.12%. The price of AZN fallen by 5.30% during the last 30 days period. For the last 5-days stocks have improved 2.02%.
The present stock price for Astrazeneca plc ADR (AZN) is $74.57. In the last trading session, the stock made a considerable jump, reaching $99.0 after an opening price of $74.57. The stock briefly fell to $67.0 before ending the session at $73.6.
Astrazeneca plc ADR ‘s stock market performance has been somewhat predictable.
52-week price history of AZN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Astrazeneca plc ADR’s current trading price is -14.95% away from its 52-week high, while its distance from the 52-week low is 21.77%. The stock’s price range during this period has varied between$61.24 and $87.68. The Astrazeneca plc ADR’s shares, which operate in the Healthcare, saw a trading volume of around 3.43 million for the day, a figure considerably lower than their average daily volume of 4.75 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Astrazeneca plc ADR (AZN) has experienced a quarterly rise of 6.42% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 231.20B and boasts a workforce of 94300 employees.
Astrazeneca plc ADR: Analysts’ Ratings Unveiled
As of right now, 7 analysts are rating Astrazeneca plc ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts are recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 71.08, with a change in price of -3.03. Similarly, Astrazeneca plc ADR recorded 5,175,126 in trading volume during the last 100 days, posting a change of -3.90%.
AZN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for AZN stands at 0.73. Similarly, the long-term debt-to-equity ratio is also 0.58.
AZN Stock Stochastic Average
As of today, Astrazeneca plc ADR’s raw stochastic average for the last 50 days stands at 73.38%. This is a rise compared to the raw stochastic average of the previous 20 days, which was noted at 73.38%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 69.03% and 69.56%, respectively.
